In Silico Methods for Development of Generic Drug–Device Combination Orally Inhaled Drug Products

The development of generic, single‐entity, drug–device combination products for orally inhaled drug products is challenging in part because of the complex nature of device design characteristics and the difficulties associated with establishing bioequivalence for a locally acting drug product delive...

Descripción completa

Detalles Bibliográficos
Autores principales: Walenga, Ross L., Babiskin, Andrew H., Zhao, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618094/
https://www.ncbi.nlm.nih.gov/pubmed/31044532
http://dx.doi.org/10.1002/psp4.12413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618094/
https://www.ncbi.nlm.nih.gov/pubmed/31044532
http://dx.doi.org/10.1002/psp4.12413

Ejemplares similares